1887

Abstract

We have recently shown that intranasal (i.n.) administration of -irradiated A/PR/8 [A/Puerto Rico/8/34 (H1N1)] protects mice against lethal avian influenza A/Vietnam/1203/2004 (H5N1) and other heterosubtypic influenza A infections. Here, we used -irradiated, formalin- and UV-inactivated A/PC [A/Port Chalmers/1/73 (H3N2)] virus preparations and compared their ability to induce both homologous and heterosubtypic protective immunity. Our data show that, in contrast to i.n. vaccination with formalin- or UV-inactivated virus, or the present commercially available trivalent influenza vaccine, a single dose of -ray-inactivated A/PC (-A/PC) conferred significant protection in mice against both homologous and heterosubtypic virus challenges. A multiple immunization regime was required for formalin-inactivated virus preparations to induce protective immunity against a homotypic virus challenge, but did not induce influenza A strain cross-protective immunity. The highly immunogenic -A/PC, but not formalin- or UV-inactivated A/PC, nor the currently available subvirion vaccine, elicited cytotoxic T-cell responses that are most likely responsible for the cross-protective and long-lasting immunity against highly lethal influenza A infections in mice. Finally, freeze-drying of -A/PC did not affect the ability to induce cross-protective immunity.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.018168-0
2010-06-01
2019-11-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/91/6/1450.html?itemId=/content/journal/jgv/10.1099/vir.0.018168-0&mimeType=html&fmt=ahah

References

  1. Ada, G. L. & Jones, P. D. ( 1986; ). The immune response to influenza infection. Curr Top Microbiol Immunol 128, 1–54.
    [Google Scholar]
  2. Alsharifi, M. & Müllbacher, A. ( 2010; ). The γ-irradiated influenza vaccine and the prospect of producing safe vaccines in general. Immunol Cell Biol 88, 103–104.[CrossRef]
    [Google Scholar]
  3. Alsharifi, M., Furuya, Y., Bowden, T. R., Lobigs, M., Koskinen, A., Regner, M., Trinidad, L., Boyle, D. B. & Müllbacher, A. ( 2009; ). Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections. PLoS One 4, e5336 [CrossRef]
    [Google Scholar]
  4. Andrew, S. M., Titus, J. A. & Zumstein, L. ( 2001; ). Dialysis and concentration of protein solutions. Curr Protoc Immunol Appendix 3, Appendix 3H
    [Google Scholar]
  5. Barry, D. W., Staton, E. & Mayner, R. E. ( 1974; ). Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice. Infect Immun 10, 1329–1336.
    [Google Scholar]
  6. Barry, D. W., Mayner, R. E., Staton, E., Dunlap, R. C., Rastogi, S. C., Hannah, J. E., Blackburn, R. J., Nortman, D. F. & Graze, P. R. ( 1976; ). Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Am J Epidemiol 104, 34–46.
    [Google Scholar]
  7. Blazevic, V., Trubey, C. M. & Shearer, G. M. ( 2000; ). Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses. Hum Immunol 61, 845–849.[CrossRef]
    [Google Scholar]
  8. Braciale, T. J. & Yap, K. L. ( 1978; ). Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J Exp Med 147, 1236–1252.[CrossRef]
    [Google Scholar]
  9. Budowsky, E. I., Bresler, S. E., Friedman, E. A. & Zheleznova, N. V. ( 1981; ). Principles of selective inactivation of viral genome. I. UV-induced inactivation of influenza virus. Arch Virol 68, 239–247.[CrossRef]
    [Google Scholar]
  10. Budowsky, E. I., Friedman, E. A., Zheleznova, N. V. & Noskov, F. S. ( 1991; ). Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of beta-propiolactone. Vaccine 9, 398–402.[CrossRef]
    [Google Scholar]
  11. Budowsky, E. I., Smirnov Yu, A. & Shenderovich, S. F. ( 1993; ). Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus. Vaccine 11, 343–348.[CrossRef]
    [Google Scholar]
  12. Chen, G. L., Lamirande, E. W., Jin, H., Kemble, G. & Subbarao, K. ( 2010; ). Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398, 109–114.[CrossRef]
    [Google Scholar]
  13. De Benedictis, P., Beato, M. S. & Capua, I. ( 2007; ). Inactivation of avian influenza viruses by chemical agents and physical conditions: a review. Zoonoses Public Health 54, 51–68.[CrossRef]
    [Google Scholar]
  14. De Flora, S. & Badolati, G. ( 1973a; ). Inactivation of A2-Hong Kong influenza virus by heat and by freeze-thawing. Comparison of untreated and gamma-irradiated preparations. Boll Ist Sieroter Milan 52, 293–305.
    [Google Scholar]
  15. De Flora, S. & Badolati, G. ( 1973b; ). Thermal inactivation of untreated and gamma-irradiated A2-Aichi-2-68 influenza virus. J Gen Virol 20, 261–265.[CrossRef]
    [Google Scholar]
  16. Fridman, A. L., Ermolaev, A. I., Bichurina, M. A. & Chubarova, N. I. ( 1979; ). Effect of gamma radiation on the biological characteristics of purified influenza virus. Tr Inst Im Pastera 52, 135–139.
    [Google Scholar]
  17. Goldstein, M. A. & Tauraso, N. M. ( 1970; ). Effect of formalin, beta-propiolactone, merthiolate, and ultraviolet light upon influenza virus infectivity chicken cell agglutination, hemagglutination, and antigenicity. Appl Microbiol 19, 290–294.
    [Google Scholar]
  18. IAEA ( 1973; ). The Manual on Radiation Sterilization of Medical and Biological Material: the Technical Reports Series. 149, pp. 65–70. Vienna: International Atomic Energy Agency.
  19. Ichinohe, T., Tamura, S., Kawaguchi, A., Ninomiya, A., Imai, M., Itamura, S., Odagiri, T., Tashiro, M., Takahashi, H. & other authors ( 2007; ). Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 196, 1313–1320.[CrossRef]
    [Google Scholar]
  20. Jackson, V. ( 1978; ). Studies on histone organization in the nucleosome using formaldehyde as a reversible cross-linking agent. Cell 15, 945–954.[CrossRef]
    [Google Scholar]
  21. Kantorovich-Prokudina, E. N., Kaverin, N. V., Semenova, N. P., Miasnikova, I. A. & Berezina, O. N. ( 1978; ). Preventive effect of UV-inactivated defective interfering influenza virus in experimental infection. Vopr Virusol 6, 673–677. in Russian
    [Google Scholar]
  22. Knipe, D. M. & Howley, P. M. ( 2001; ). Fields Virology, vol. 1. Philadelphia (EUA): Lippincott Williams & Wilkins.
  23. Kulevich, E. E. & Kosiakov, P. N. ( 1974; ). Immunogenic properties of A2/Hongkong/1/68 influenza virus inactivated with gamma rays. Vopr Virusol 6, 696–700. in Russian
    [Google Scholar]
  24. Lidbury, B. A., Grissell, T. V., Sizer, P. J., Pang, G. T., Clancy, R. & Cripps, A. W. ( 1997; ). Erythrocytes enhance the immunogenicity of oral vaccination with gamma irradiated influenza virus: increasing the dose of irradiation results in a significant diminution of lung IgA response. Vaccine 15, 1529–1537.[CrossRef]
    [Google Scholar]
  25. Lowy, R. J., Vavrina, G. A. & LaBarre, D. D. ( 2001; ). Comparison of gamma and neutron radiation inactivation of influenza A virus. Antiviral Res 52, 261–273.[CrossRef]
    [Google Scholar]
  26. Martinson, H. G., True, R., Lau, C. K. & Mehrabian, M. ( 1979; ). Histon–histone interactions within chromatin. Preliminary location of multiple contact sites between histones 2A, 2B, and 4. Biochemistry 18, 1075–1082.[CrossRef]
    [Google Scholar]
  27. Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D. & Nedrud, J. G. ( 1992; ). Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 89, 6901–6905.[CrossRef]
    [Google Scholar]
  28. Mazanec, M. B., Coudret, C. L. & Fletcher, D. R. ( 1995a; ). Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 69, 1339–1343.
    [Google Scholar]
  29. Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D., Peterra, J. & Nedrud, J. G. ( 1995b; ). Intracellular neutralization of Sendai and influenza viruses by IgA monoclonal antibodies. Adv Exp Med Biol 371A, 651–654.
    [Google Scholar]
  30. Migunov, A. I., Aron, R. A., Sirotkin, A. K., Chernina, L. F. & Kuznetsov, O. K. ( 1986; ). Physicochemical characteristics of an influenza virus population inactivated by gamma rays. Radiobiologiia 26, 647–651.
    [Google Scholar]
  31. Müllbacher, A., Ada, G. L. & Hla, R. T. ( 1988; ). Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol Cell Biol 66, 153–157.[CrossRef]
    [Google Scholar]
  32. Müllbacher, A., Hill, A. B., Blanden, R. V., Cowden, W. B., King, N. J. & Hla, R. T. ( 1991; ). Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J Immunol 147, 1765–1772.
    [Google Scholar]
  33. Müllbacher, A., Lobigs, M., Alsharifi, M. & Regner, M. ( 2006; ). Cytotoxic T-cell immunity as a target for influenza vaccines. Lancet Infect Dis 6, 255–256.[CrossRef]
    [Google Scholar]
  34. Nguyen, H. H., Moldoveanu, Z., Novak, M. J., van Ginkel, F. W., Ban, E., Kiyono, H., McGhee, J. R. & Mestecky, J. ( 1999; ). Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8+ cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 254, 50–60.[CrossRef]
    [Google Scholar]
  35. Noack, K., Tischner, H., Brauniger, S., Nordheim, W. & Pohl, W. D. ( 1986; ). Long-term effect of oral immunization against influenza with a gamma ray-inactivated vaccine in mice. Z Erkr Atmungsorgane 166, 286–289.
    [Google Scholar]
  36. Ortbals, D. W. & Liebhaber, H. ( 1978; ). Comparison of immunogenicity of a whole virion and a subunit influenza vaccine in adults. J Clin Microbiol 8, 431–434.
    [Google Scholar]
  37. Palese, P. ( 2006; ). Making better influenza virus vaccines? Emerg Infect Dis 12, 61–65.[CrossRef]
    [Google Scholar]
  38. Pang, G. T., Clancy, R. L., O'Reilly, S. E. & Cripps, A. W. ( 1992; ). A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization. J Virol 66, 1162–1170.
    [Google Scholar]
  39. Plotkin, S. A., Orenstein, W. A. & Offit, P. A. ( 2008; ). Vaccines. Philadelphia: W. B. Saunders & Co.
  40. Polianskaia, Nlu. ( 1979; ). Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation. Tr Inst Im Pastera 52, 107–110. in Russian
    [Google Scholar]
  41. Quilligan, J. J., Jr, Francis, T., Jr & Minuse, E. ( 1949; ). Reactions to an influenza virus vaccine in infants and children. Am J Dis Child 78, 295–301.
    [Google Scholar]
  42. Redfield, D. C., Richman, D. D., Oxman, M. N. & Kronenberg, L. H. ( 1981; ). Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells. Infect Immun 32, 1216–1226.
    [Google Scholar]
  43. Salk, J. E. ( 1948; ). Reactions to concentrated influenza virus vaccines. J Immunol 58, 369–395.
    [Google Scholar]
  44. Sheffield, F. W., Smith, W. & Belyavin, G. ( 1954; ). Purification of influenza virus by red-cell adsorption and elution. Br J Exp Pathol 35, 214–222.
    [Google Scholar]
  45. Szretter, K. J., Balish, A. L. & Katz, J. M. ( 2006; ). Influenza: propagation, quantification, and storage. Curr Protoc Microbiol Chapter 15, Unit 15G.1
    [Google Scholar]
  46. Takada, A., Kuboki, N., Okazaki, K., Ninomiya, A., Tanaka, H., Ozaki, H., Itamura, S., Nishimura, H., Enami, M. & other authors ( 1999; ). Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J Virol 73, 8303–8307.
    [Google Scholar]
  47. Takada, A., Matsushita, S., Ninomiya, A., Kawaoka, Y. & Kida, H. ( 2003; ). Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 21, 3212–3218.[CrossRef]
    [Google Scholar]
  48. Tumpey, T. M., Renshaw, M., Clements, J. D. & Katz, J. M. ( 2001; ). Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 75, 5141–5150.[CrossRef]
    [Google Scholar]
  49. WHO ( 2005; ). Immunization against diseases of public health importance. In Fact Sheets. No. 288, WHO.
  50. Zheleznova, N. V. ( 1982; ). Method of influenza virus UV inactivation applied to the manufacture of an inactivated chromatographic influenza vaccine. Tr Inst Im Pastera 59, 81–88.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.018168-0
Loading
/content/journal/jgv/10.1099/vir.0.018168-0
Loading

Data & Media loading...

Supplements

vol. , part 6, pp. 1450 - 1460

Haemagglutination activity of live and inactivated influenza virus A/PC preparations [PDF](15 KB)



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error